| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Indication | Essai clinique |
|---|---|---|---|---|---|
| anti-glypican-2 CAR T-cell therapy (Childrens Hospital of Philadelphia/Kite Pharma) | Phase 1 Clinical | Childrens Hospital of Philadelphia | Rhabdomyosarcoma; Small Cell Lung Carcinoma; Urinary Bladder Neoplasms; Neuroblastoma | Details | |
| GPC2 CAR-T cell therapy(Childrens Hospital of Philadelphia/Tmunity Therapeutics) | TmGPC2-01-CAR-T | Phase 1 Clinical | Childrens Hospital of Philadelphia | Small Cell Lung Carcinoma; Urinary Bladder Neoplasms; Neuroblastoma | Details |